BIOMAT Database Logo BIOMAT Database Logo

[Kinetics of human leukemic myeloblasts after use of cytosine-arabinoside]. 1973

A Faille, and Y Najean, and J Bernard

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Faille, and Y Najean, and J Bernard
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
February 1981, Clinical science (London, England : 1979),
A Faille, and Y Najean, and J Bernard
Effect of interleukin 3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts.
August 1990, Experimental hematology,
A Faille, and Y Najean, and J Bernard
Cell proliferation and protein synthesis in human leukaemic myeloblasts after cytosine arabinoside therapy.
February 1976, British journal of haematology,
A Faille, and Y Najean, and J Bernard
Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.
January 1981, Cancer chemotherapy and pharmacology,
A Faille, and Y Najean, and J Bernard
Perturbation of cell cycle of human leukaemic myeloblasts in vivo by cytosine arabinoside.
January 1973, Scandinavian journal of haematology,
A Faille, and Y Najean, and J Bernard
[Clinical use of cytosine arabinoside in childhood. II. Cytosine arabinoside in the prevention and therapy of leukemic meningosis].
September 1975, Minerva pediatrica,
A Faille, and Y Najean, and J Bernard
Cytosine arabinoside cerebrospinal fluid kinetics.
June 1984, Clinical pharmacology and therapeutics,
A Faille, and Y Najean, and J Bernard
[Cytosine arabinoside in the treatment of leukemic meningitis].
January 1972, Haematologica,
A Faille, and Y Najean, and J Bernard
Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
September 1977, British journal of cancer,
A Faille, and Y Najean, and J Bernard
Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells.
January 1990, Leukemia research,
Copied contents to your clipboard!